Exelixis Inc (EXEL)
34.77
+0.48
(+1.40%)
USD |
NASDAQ |
Nov 05, 16:00
35.00
+0.23
(+0.66%)
After-Hours: 18:59
Exelixis Market Cap: 9.930B for Nov. 5, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 04, 2024 | 9.793B |
| November 01, 2024 | 9.744B |
| October 31, 2024 | 9.481B |
| October 30, 2024 | 9.264B |
| October 29, 2024 | 8.205B |
| October 28, 2024 | 8.139B |
| October 25, 2024 | 7.959B |
| October 24, 2024 | 8.028B |
| October 23, 2024 | 8.088B |
| October 22, 2024 | 8.233B |
| October 21, 2024 | 8.185B |
| October 18, 2024 | 8.259B |
| October 17, 2024 | 8.305B |
| October 16, 2024 | 8.388B |
| October 15, 2024 | 8.145B |
| October 14, 2024 | 7.499B |
| October 11, 2024 | 7.496B |
| October 10, 2024 | 7.347B |
| October 09, 2024 | 7.267B |
| October 08, 2024 | 7.256B |
| October 07, 2024 | 7.519B |
| October 04, 2024 | 7.619B |
| October 03, 2024 | 7.499B |
| October 02, 2024 | 7.573B |
| October 01, 2024 | 7.516B |
| Date | Value |
|---|---|
| September 30, 2024 | 7.416B |
| September 27, 2024 | 7.405B |
| September 26, 2024 | 7.485B |
| September 25, 2024 | 7.434B |
| September 24, 2024 | 7.496B |
| September 23, 2024 | 7.519B |
| September 20, 2024 | 7.536B |
| September 19, 2024 | 7.653B |
| September 18, 2024 | 7.650B |
| September 17, 2024 | 7.873B |
| September 16, 2024 | 7.836B |
| September 13, 2024 | 7.548B |
| September 12, 2024 | 7.505B |
| September 11, 2024 | 7.596B |
| September 10, 2024 | 7.505B |
| September 09, 2024 | 7.277B |
| September 06, 2024 | 7.174B |
| September 05, 2024 | 7.294B |
| September 04, 2024 | 7.305B |
| September 03, 2024 | 7.368B |
| August 30, 2024 | 7.425B |
| August 29, 2024 | 7.422B |
| August 28, 2024 | 7.365B |
| August 27, 2024 | 7.340B |
| August 26, 2024 | 7.340B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
4.417B
Minimum
Mar 16 2020
9.930B
Maximum
Nov 05 2024
6.450B
Average
6.459B
Median
Market Cap Benchmarks
| Merck & Co Inc | 257.66B |
| Eli Lilly and Co | 765.50B |
| Novavax Inc | 1.514B |
| BioCryst Pharmaceuticals Inc | 1.459B |
| Biomarin Pharmaceutical Inc | 12.59B |
Market Cap Related Metrics
| PE Ratio | 22.29 |
| PS Ratio | 5.028 |
| PEG Ratio | 0.0495 |
| Price to Book Value | 4.364 |
| Price to Free Cash Flow | 25.85 |
| Price | 34.77 |
| Earnings Yield | 4.49% |
| PEGY Ratio | 0.0495 |
| Operating PE Ratio | 17.21 |
| Normalized PE Ratio | 19.56 |